The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
EWS/FLI-1 is a chimeric protein formed by a tumor-specific 11;22 translocation found in both Ewing's sarcoma and primitive neuroectodermal tumor of childhood. EWS/FLI-1 has been shown to be a potent transforming gene, suggesting that it plays an important role in the genesis of these human tumors. We now demonstrate that EWS/FLI-1 has the characteristics of an aberrant transcription factor. Subcellular fractionation experiments localized the EWS/FLI-1 protein to the nucleus of primitive neuroectodermal tumor cells. EWS/FLI-1 specifically bound in vitro an ets-2 consensus sequence similarly to normal FLI-1. When coupled to a GAL4 DNA-binding domain, the amino-terminal EWS/FLI-1 region was a much more potent transcriptional activator than the corresponding amino-terminal domain of FLI-1. Finally, EWS/FLI-1 efficiently transformed NIH 3T3 cells, but FLI-1 did not. These data suggest that EWS/FLI-1, functioning as a transcription factor, leads to a phenotype dramatically different from that of cells expressing FLI-1. EWS/FLI-1 could disrupt normal growth and differentiation either by more efficiently activating FLI-1 target genes or by inappropriately modulating genes normally not responsive to FLI-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The strong transactivation activity in the N terminus of EWS contributes to the function of the resulting oncogenic fusion protein (185).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [185]
Citations
Cites
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 3×
“This polypeptide fragment included EWS amino acid residues 244 to 264 (6) fused to residues 241 to 284 of FLI-1 (30).”
BackgroundMethodde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Kamps, M. P., Murre, C., Sun, X.-H., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90658-2 · Cited by 697
Dalton, S., & Treisman, R. (1992) · Cell · doi:10.1016/0092-8674(92)90194-h · Cited by 672
Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 662
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Stringer, K. F., Ingles, C. J., & Greenblatt, J. (1990) · Nature · doi:10.1038/345783a0 · Cited by 579
Cited by
Items 301–400 of 562
PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1
Giorgi, C., Boro, A., Rechfeld, F., Lopez-Garcia, L. A., Gierisch, M. E., Schäfer, B. W., & Niggli, F. K. (2015) · Oncotarget · doi:10.18632/oncotarget.5000 · Cited by 25
Stimulation of hTAFII68 (NTD)‐mediated transactivation by v‐Src
Lee, H. J., Kim, S., Pelletier, J., & Kim, J. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00314-x · Cited by 25
Abadie, A., Besançon, F., & Wietzerbin, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207614 · Cited by 25
Ewing’s Sarcoma Family of Tumors
van Valen, F. (2002) · Human cell culture · doi:10.1007/0-306-46872-7_3 · Cited by 25
Camões, M. J., Paulo, P., Ribeiro, F. R., Barros-Silva, J. D., Almeida, M. R., Costa, V. L., Cerveira, N., Skotheim, R. I., Lothe, R. A., Henrique, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049819 · Cited by 24
Sengupta, A., Rahman, M. H., Mateo‐Lozano, S., Tirado, Ò. M., & Notario, V. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2016 · Cited by 24
Characterization of a new brain‐specific isoform of the EWS oncoprotein
Melot, T., Dauphinot, L., Sévenet, N., Radvanyi, F., & Delattre, O. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02251.x · Cited by 23
Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor
Hartono, A. B., Kang, H., Shi, L., Phipps, W. E., Ungerleider, N., Giardina, A., Chen, W., Spraggon, L., Somwar, R., Moroz, K., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00395-6 · Cited by 23
Przybył, J., Kozak, K., Koseła-Paterczyk, H., Falkowski, S., Świtaj, T., Ługowska, I., Szumera‐Ciećkiewicz, A., Ptaszyński, K., Grygalewicz, B., Chechlińska, M., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0109-2 · Cited by 23
Cytogenetics and the biological basis of sarcomas
Skapek, S. X., Shaffer, L. G., & Barker, J. A. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199807000-00008 · Cited by 23
Friedrichs, N., Kriegl, L., Poremba, C., Schaefer, K., Gabbert, H. E., Shimomura, A., Paggen, E., Merkelbach‐Bruse, S., & Buettner, R. (2006) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200606000-00004 · Cited by 23
Fused in sarcoma regulates DNA replication timing and kinetics
Jia, W., Kim, S. H., Scalf, M., Tonzi, P., Millikin, R. J., Guns, W. M., Liu, L., Mastrocola, A. S., Smith, L. M., Huang, T. T., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101049 · Cited by 22
Accumulation of pre-let-7g and downregulation of mature let-7g with the depletion of EWS
Sohn, E. J., Park, J., Kang, S.-I., & Wu, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.041 · Cited by 22
Clinical features of molecular pathology of solid tumours in childhood
Messahel, B., Nash, R., Jeffrey, I., Pritchard‐Jones, K., & Hing, S. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70209-6 · Cited by 22
Identification of EWS/FLI-1 transcripts in giant-cell tumor of bone
Scotlandi, K., Chano, T., Benini, S., Serra, M., Manara, M. C., Cerisano, V., Picci, P., & Baldini, N. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000801)87:3<328::aid-ijc4>3.0.co;2-1 · Cited by 22
Microsatellites with Macro-Influence in Ewing Sarcoma
Monument, M. J., Johnson, K. M., Grossmann, A. H., Schiffman, J. D., Randall, R. L., & Lessnick, S. L. (2012) · Genes · doi:10.3390/genes3030444 · Cited by 21
Self-citationSoft tissue sarcomas of infancy
Palumbo, J. S., & Zwerdling, T. (1999) · Seminars in Perinatology · doi:10.1016/s0146-0005(99)80038-x · Cited by 21
Antitumor Vectorized Oligonucleotides in a Model of Ewing Sarcoma: Unexpected Role of Nanoparticles
Elhamess, H., Bertrand, J., Maccario, J., Maksimenko, A., & Malvy, C. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0197 · Cited by 21
Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1
Chan, D. W., Wilson, T. J., Xu, D., Cowdery, H. E., Sanij, E., Hertzog, P. J., & Kola, I. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600669 · Cited by 21
Suppression of the Ewing’s sarcoma phenotype by FLI1/ERF repressor hybrids
Athanasiou, M., Gallic, L. L., Watson, D. K., Blair, D. G., & Mavrothalassitis, G. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700220 · Cited by 20
New developments in immunotherapy for pediatric solid tumors
Schultz, L. M., Majzner, R. G., Davis, K. L., & Mackall, C. L. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000564 · Cited by 20
Combinatorial Drug Screening Identifies Ewing Sarcoma–specific Sensitivities
Radic-Sarikas, B., Tsafou, K. P., Emdal, K. B., Papamarkou, T., Huber, K., Mutz, C., Toretsky, J. A., Bennett, K. L., Olsen, J. V., Brunak, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0235 · Cited by 20
Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
Kowalewski, A. A., Randall, R. L., & Lessnick, S. L. (2010) · Sarcoma · doi:10.1155/2011/598704 · Cited by 20
Self-citationMolecular Alterations in Pediatric Sarcomas: Potential Targets for Immunotherapy
Goletz, T. J., Mackall, C. L., Berzofsky, J. A., & Helman, L. J. (1998) · Sarcoma · doi:10.1080/13577149878037 · Cited by 20
Cytogenetics and the biologic basis of sarcomas
Skapek, S. X., & Chui, C. H. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00007 · Cited by 20
Patócs, B., Németh, K., Garami, M., Arató, G., Kovalszky, I., Szendrői, M., & Fekete, G. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0126-8 · Cited by 20
Primary Ewing´s sarcoma/Primitive neuroectodermal tumor of the kidney: An infrequent finding
Parada, D., Godoy, A., Liuzzi, F., Peña, K. B., Romero, A., & Parada, A. M. (2007) · Archivos Españoles de Urología · doi:10.4321/s0004-06142007000300020 · Cited by 20
Molecular analysis of a t(II;22) translocation junction in a case of Ewing's sarcoma
Bhagirath, T., Abe, S., Nojirna, T., & Yoshida, M. C. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870130209 · Cited by 19
Abnormal phase separation of biomacromolecules in human diseases
Zhang, S., Pei, G., Li, B., Li, P., & Lin, Y. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023139 · Cited by 19
Dohjima, T., Ohno, T., Banno, Y., Nozawa, Y., Wenyi, Y., & Shimizu, K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1998.0870 · Cited by 19
Ewing Sarcoma Family of Tumors
Galindo, C. R., Navid, F., Khoury, J. D., & Krasin, M. J. (2005) · Springer eBooks · doi:10.1007/3-540-29447-3_9 · Cited by 19
The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells
Filion, C., & Labelle, Y. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.040 · Cited by 19
Archer, L. K., Frame, F. M., & Maitland, N. J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.006 · Cited by 18
Differential Disruption of EWS-FLI1 Binding by DNA-Binding Agents
Chen, C., Wonsey, D. R., Lemieux, M. E., & Kung, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069714 · Cited by 18
The Clone Wars – Revenge of the Metastatic Rogue State: The Sarcoma Paradigm
Spraker‐Perlman, H. L., Price, S. L., Chaturvedi, A. P., Schiffman, J. D., Jones, K. B., Lessnick, S. L., Beckerle, M. C., & Randall, R. L. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00002 · Cited by 18
Self-citationThe Landscape of Regulatory Noncoding RNAs in Ewing’s Sarcoma
Barrett, C., Budhiraja, A., Parashar, V., & Batish, M. (2021) · Biomedicines · doi:10.3390/biomedicines9080933 · Cited by 18
Han, C., Sun, L.-Y., Wang, W., Sun, Y., & Chen, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz080 · Cited by 18
Smith, P. G., Burchill, S. A., Brooke, D., Coletta, P. L., & Whitehouse, A. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700788 · Cited by 18
Borowski, A., van Valen, F., Ulbrecht, M., Weiss, E. H., Blasczyk, R., Jorgens, H., Göbel, U., & Schneider, E. M. (1999) · Immunobiology · doi:10.1016/s0171-2985(99)80029-1 · Cited by 18
Moritake, H., Sugimoto, T., Kuroda, H., Hidaka, F., Takahashi, Y., Tsuneyoshi, M., Yoshida, M. A., Cui, Q., Akiyoshi, K., Izumi, T., et al. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00129-8 · Cited by 18
Sartori, G., Napoli, S., Cascione, L., Chung, E. Y., Priebe, V., Arribas, A. J., Mensah, A. A., Dall’Angelo, M., Falzarano, C., Barnabei, L., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02159-3 · Cited by 17
Molecular diagnostics complementing morphology in superficial mesenchymal tumors
Cheah, A. L., Goldblum, J. R., & Billings, S. D. (2013) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2012.01.005 · Cited by 17
Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions
Corveleyn, A., Janssen, H., Martini, A. C., Somers, R., Cools, J., & Marynen, P. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20369 · Cited by 17
Yoon, Y., Park, H., Kim, S., Nguyen, P. T., Hyeon, S. J., Chung, S., Im, H., Lee, J.-H., Lee, S. B., & Ryu, H. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.2.103 · Cited by 17
EWS-FLI1 Causes Neuroepithelial Defects and Abrogates Emigration of Neural Crest Stem Cells
Coles, E. G., Lawlor, E. R., & Bronner-Fraser, M. E. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0133 · Cited by 16
Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
Monument, M. J., Bernthal, N. M., & Randall, R. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00024 · Cited by 16
Targeting sarcomas: therapeutic targets and their rational
Ordóñez, J. L., Martins, A. S., Osuna, D., Madoz‐Gúrpide, J., & de Álava, E. (2008) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2008.07.005 · Cited by 16
Comparison of latino and non-Latino patients with Ewing sarcoma
Sharib, J. M., Horvai, A., Hazard, F. K., Daldrup-Link, H. E., Goldsby, R. E., Marina, N. M., & DuBois, S. G. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24745 · Cited by 16
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
Namatame, N., Tamaki, N., Yoshizawa, Y., Okamura, M., Nishimura, Y. H., Yamazaki, K., Tanaka, M., Nakamura, T., Semba, K., Yamori, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26216 · Cited by 16
Zou, Y. S., Morsberger, L. A., Hardy, M., Ghabrial, J., Stinnett, V., Murry, J. B., Long, P., Kim, A., Pratilas, C. A., Llosa, N. J., et al. (2023) · Genes · doi:10.3390/genes14061139 · Cited by 16
The hTAFII68‐TEC fusion protein functions as a strong transcriptional activator
Kim, S., Lee, H. J., Jun, H. J., & Kim, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23379 · Cited by 16
Cellular Immunotherapy Strategies for Ewing Sarcoma
Rössig, C. (2014) · Immunotherapy · doi:10.2217/imt.14.36 · Cited by 15
Generation and Characterization of Monoclonal Antibodies against the ERGB/FLI-1 Transcription Factor
Zhang, X.-K., Papas, T. S., BHAT, N. K., & Watson, D. K. (1995) · Hybridoma · doi:10.1089/hyb.1995.14.563 · Cited by 15
EWS-WT1 Chimeric Protein in Desmoplastic Small Round Cell Tumor is a Potent Transactivator of FGFR4
Saito, T. (2012) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000164 · Cited by 15
Wang, Y., Feldman, E. R., Bullard, W. L., & Tibbetts, S. A. (2019) · mBio · doi:10.1128/mbio.00996-19 · Cited by 15
Lim, B., Jun, H. J., Kim, A., Kim, S., Choi, J. H., & Kim, J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs164 · Cited by 15
Genetic drivers and cells of origin in sarcomagenesis
Kannan, S., Lock, I. C., Ozenberger, B. B., & Jones, K. B. (2021) · The Journal of Pathology · doi:10.1002/path.5617 · Cited by 14
Cytogenetics of soft tissue tumors
Fletcher, J. A. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-6121-7_2 · Cited by 14
Development of an Ewing sarcoma cell line with resistance to EWS‑FLI1 inhibitor YK‑4‑279
Conn, E. J., Hour, S., Allegakoen, D. V., Graham, G. T., Petro, J. R., Kouassi‐Brou, M., Hong, S. H., Selvanathan, S. P., �elik, H., Toretsky, J. A., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10948 · Cited by 14
He, T., Surdez, D., Rantala, J., Haapa-Paananen, S. M., Ban, J., Kauer, M. O., Tomazou, E. M., Fey, V., Alonso, J., Kovar, H., et al. (2016) · Gene · doi:10.1016/j.gene.2016.10.021 · Cited by 14
TEL Induces Aggregation in Transformed Cells and Induces Tube Formation in NIH3T3-UCLA Cells
Rompaey, L. V., Holland, E. C., & Grosveld, G. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6513 · Cited by 13
The Potential for molecular therapeutic targets in Ewing’s sarcoma
McAllister, N., & Lessnick, S. L. (2005) · Current Treatment Options in Oncology · doi:10.1007/s11864-005-0025-y · Cited by 13
Self-citationBölling, T., Braun‐Munzinger, G., Burdach, S. E. G., Calaminus, G., Craft, A. W., Delattre, O., Deley, M. L., Dirksen, U., Dockhorn‐Dworniczak, B., Dunst, J., et al. (2015) · Klinische Pädiatrie · doi:10.1055/s-0035-1545263 · Cited by 13
Jully, B., Ramshankar, V., Gopisetty, G., Sabitha, K., & Rajkumar, T. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-513 · Cited by 13
Transcripts, Transcripts, Everywhere
de Álava, E. (2001) · Advances in Anatomic Pathology · doi:10.1097/00125480-200109000-00003 · Cited by 13
Meric, F., Liao, Y., Lee, W. P., Pollock, R. E., & Hung, M. (2000) · PubMed · Cited by 13
Lee, O. W., Rodrigues, C., Lin, S., Luo, W., Jones, K. M., Brown, D. W., Zhou, W., Karlins, E., Khan, S. M., Baulande, S., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.01.017 · Cited by 12
Asrani, K. V., Mendes, A. A. D. A., Woo, J., Abadchi, S. N., Vidotto, T., Imada, E. L., Skaist, A. M., Feng, K., Liu, H. B., Kasbe, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63885-2 · Cited by 12
Molecular Genetic Aspects of Solid Tumors in Childhood
Davidoff, A. M., & Hill, D. A. (2001) · Seminars in Pediatric Surgery · doi:10.1053/spsu.2001.24700 · Cited by 12
Minoletti, F., Sozzi, G., Tornielli, S., Pilotti, S., Azzarelli, A., Pierotti, M. A., & Radice, P. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199812)186:4<434::aid-path199>3.0.co;2-x · Cited by 12
Lee, J., Hopcus-Niccum, D. J., Mulvihill, J. J., & Li, S. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.11.003 · Cited by 12
Thomas, G., Faulkes, D. J., Gascoyne, D. M., & Latchman, D. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(04)00904-0 · Cited by 12
Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis
Martínez-López, M. F., & López‐Gil, J. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030871 · Cited by 11
Bidirectionality and transcriptional activity of the EWSR1 promoter region
Möller (2009) · Oncology Reports · doi:10.3892/or_00000267 · Cited by 11
The impact of fusion genes on cancer stem cells and drug resistance
Panicker, S., Venkatabalasubramanian, S., Pathak, S., & Ramalingam, S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04203-4 · Cited by 11
Primary Ewing's Sarcoma/Primitive Neuroectodermal Tumor of of Kidney - a Diagnostic Dilemma.
Chakrabarti, N., Dewasi, N., Das, S., Bandyopadhyay, A., & Bhaduri, N. (2015) · PubMed Central · Cited by 11
Transdifferentiation of neoplastic cells
Zhang, Z., Yuan, X., Li, L.-H., & Xie, F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1435 · Cited by 10
Self, C., MacQuarrie, K. L., & Cost, C. R. (2022) · Pediatrics in Review · doi:10.1542/pir.2021-005065 · Cited by 10
The Role of Molecular Testing in the Diagnosis of Cutaneous Soft Tissue Tumors
Cheah, A. L., & Billings, S. D. (2012) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2012.07.008 · Cited by 10
Rosoff, P. M., Hatcher, S., & West, D. C. (2000) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(200006)34:6<407::aid-mpo5>3.0.co;2-x · Cited by 10
Kujoth, G. C., Robinson, D. F., & Fahl, W. E. (1998) · PubMed · Cited by 9
Proctor, A., Brownhill, S. C., & Burchill, S. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.011 · Cited by 9
Aberrant laminin beta-3 isoforms downstream of EWS-ETS fusion genes in ewing family tumors
Irifune, H., Nishimori, H., Watanabe, G., Yoshida, K., Ikeda, T., Matsui, C., Morohashi, M., Kawaguchi, S., Nagoya, S., Wada, T., et al. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.4.1623 · Cited by 9
CASE 6: INTRA-ABDOMINAL POLYPHENOTYPIC TUMOR
Thorner, P. S. (1996) · Pediatric Pathology & Laboratory Medicine · doi:10.1080/15513819609168675 · Cited by 9
Krams, M., Peters, J., Boeckel, F., Raether, A., Ambros, P. F., Parwaresch, R. M., & Harms, D. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000252 · Cited by 9
DuBois, S. G., Grier, H. E., & Lessnick, S. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00021-2 · Cited by 8
Self-citationTelomere maintenance in soft tissue sarcomas
Eastley, N. C., Ottolini, B., Garrido, C., Shaw, J., McCulloch, T. A., Ashford, R. U., & Royle, N. J. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204151 · Cited by 8
Isoyama, S., Tamaki, N., Noguchi, Y., Okamura, M., Yoshimatsu, Y., Kondo, T., Suzuki, T., Yaguchi, S., & Dan, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05690-7 · Cited by 8
Genetics and Epigenetics of the TET-ETS Translocation Network
Staege, M. S., & Max, D. (2009) · Genetics & Epigenetics · doi:10.4137/geg.s2815 · Cited by 8
Gostout, B. S., Lindor, N. M., DiMarco, C. S., Peethambaram, P. P., & Clayton, A. C. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00416-5 · Cited by 8
García-Domínguez, D. J., Hontecillas‐Prieto, L., Andrés‐León, E., Sánchez-Molina, S., Rodríguez‐Núñez, P., Morón, F. J., Hajji, N., Mackintosh, C., & de Álava, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234243 · Cited by 7
ETS transcription factors and targets in tumour invasion, angiogenesis and bone metastasis
Seth, A. K., Catzavelos, C., Vary, C., & Ascione, R. (2001) · Emerging Therapeutic Targets · doi:10.1517/14728222.5.1.87 · Cited by 7
The hollow fiber assay for drug responsiveness in the Ewing’s sarcoma family of tumors
Bridges, E., Bibby, M. C., & Burchill, S. A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.02.042 · Cited by 7
Pisconti, S., Scarpati, G. D. V., Buonerba, C., Messinese, S., Carella, R., Marzo, M. D., Lorenzo, G. D., Lazzari, G., Perri, F., & Solla, R. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s213233 · Cited by 7
Lee, C.-J., Ahn, H., Lee, S. B., Shin, J.-Y., Park, W., Kim, J., Lee, J.-H., Ryu, H., & Kim, S. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0195-4 · Cited by 7
Laboratory Evaluation of Pediatric Bone and Soft-Tissue Tumors
Craver, R. D. (1996) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)32092-7 · Cited by 7
Structure and cooperative formation of a FLI1 filament on contiguous GGAA DNA sites
Hou, C., & Tsodikov, O. V. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf205 · Cited by 6
Honsei, N., Ikuta, T., Kawana, K., Kaneko, Y., & Kawajiri, K. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.3.689 · Cited by 6
New biology and therapies in soft tissue sarcomas
Antman, K. H. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00127-5 · Cited by 6
Principles of Pediatric Oncology, Genetics of Cancer, and Radiation Therapy
Krasin, M. J., & Davidoff, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07255-7.00028-3 · Cited by 6
Metadata
- Authors
- May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-12
- Volume
- 13
- Issue
- 12
- Pages
- 7393-7398
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364810
- OpenAlex
- W1789215739
- Cited by
- 497
- References
- 33
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 13 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 8 · 2016: 16 · 2015: 15 · 2014: 22 · 2013: 25 · 2012: 20
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- National Institute of General Medical Sciences (T32GM008042)
- National Institute of Allergy and Infectious Diseases (T32AI007126)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- FLI1, Ewing sarcoma, primitive neuroectodermal tumor, 22 translocation, transcriptional activator, GAL4 DNA-binding domain, nuclear localization
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Molecular Sequence Data, Oncogenes, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Sarcoma, Ewing, Translocation, Genetic, Trans-Activators, 3T3 Cells, Mice, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.